Biospecimen Acquisition From Human Subjects
National Cancer Institute (NCI)
Summary
This study will collect blood from patients with cancer to study the level of cells which decrease the immune response (suppressor cells) before and after chemotherapy. Patients 18 years of age and older with cancer may participate. This study does not involve treatment. Participants will have about 50 ml (3 tablespoonfuls) of blood drawn. Depending on their condition, patients may be invited to enroll in a clinical research study involving chemotherapy, radiotherapy, or surgery. Additional 40-ml blood samples may be drawn during the course of treatment.
Description
Background: * Correlative studies performed on biospecimens of human subjects can be used to investigate the biology of solid tumors, inform the development of new strategies for treating those cancers, and evaluate these new therapeutic approaches. Specific areas of interest include, but are not limited to: * the underlying mechanisms of tumor-specific immune response and suppression in cancer patients * genetic and molecular profiling of tumors through circulating tumor cell (cTC), circulating DNA, and tissue analysis * investigation of potential early diagnostic and prognostic indicators f…
Eligibility
- Age range
- 18+ years
- Sex
- All
- Healthy volunteers
- Yes
* INCLUSION CRITERIA: Patients with a known or suspected malignancy and healthy volunteers 18 years of age and older are eligible. Performance status of ECOG 0, 1, 2, or 3 for admission to this protocol. Ability to understand and the willingness to sign a written informed consent document. INCLUSION FOR APHERESIS: Note: Effective with Amendment CC, participants will no longer be asked to undergo apheresis. This content is being retained for historical reference. Hemoglobin greater than or equal to 10 mg/dL and platelet count \> 75,000/mm(3) Weight greater than 25 kg HIV negative Proth…
Location
- National Institutes of Health Clinical CenterBethesda, Maryland